• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Trop Pediatr . Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience

tetano

Editor, Senior Moderator
J Trop Pediatr


. 2021 Jul 2;67(3):fmab070.
doi: 10.1093/tropej/fmab070.
Mucocutaneous Findings of Multisystem Inflammatory Syndrome in Children: A Single-Center Experience


Elif Böncüoğlu[SUP] 1 [/SUP], Elif Kıymet[SUP] 1 [/SUP], Şahika Şahinkaya[SUP] 1 [/SUP], Ela Cem[SUP] 1 [/SUP], Miray Yılmaz Çelebi[SUP] 1 [/SUP], Mine Düzgöl[SUP] 1 [/SUP], Dorukhan Besin[SUP] 1 [/SUP], Kamile Ötiken Arıkan[SUP] 1 [/SUP], Aybüke Akaslan Kara[SUP] 1 [/SUP], Nuri Bayram[SUP] 1 [/SUP], İlker Devrim[SUP] 1 [/SUP]



Affiliations

Abstract

This descriptive study aimed to evaluate the frequency and the types of mucocutaneous manifestations associated with multisystem inflammatory syndrome in children (MIS-C). A cohort of 49 patients was reviewed. There were 6 patients (12.2%) whose mucocutaneous findings were observed by the clinicians on admission, whereas 26 (53%) patients had at least one of the histories of rash or desquamation associated with fever before the admission. Exanthems in our experience demonstrated a variety of morphologies, including morbilliform, urticarial, petechial, and maculopapular forms. Mucosal involvement (conjunctivitis and strawberry tongue) was observed only in 2/6 (34%) patients. In the coronavirus disease 2019 pandemic era, while evaluating the criteria for MIS-C, the history of previous cutaneous findings given by parents/caregivers is also important. There was no pathognomonic rash for MIS-C and a variety of cutaneous findings with a short lifespan can be associated with MIS-C.

Keywords: COVID-19; SARS-CoV-2; children; multisystem inflammatory syndrome in children; skin rashes.
 
Back
Top Bottom